Latest Headlines

  1. Blood Test Using Artificial Intelligence Paves The Way For Early Diagnosis Of Leprosy 4/6/2026

    A new blood test combined with a standardized questionnaire and artificial intelligence may transform the way leprosy is diagnosed in Brazil. Researchers at the University of São Paulo (USP) tested the new test in Brazil using blood samples collected during a COVID-19 population survey.

  2. GeneProof Announces CMV IVDR Launch On The myCROBE™ Fully Automated System For Transplant Care 4/2/2026

    GeneProof, a molecular diagnostics manufacturer and part of NuvinkaDx, announced several significant product and regulatory milestones.

  3. Cancer Is Striking Earlier - Superpower And GRAIL Are Partnering To Expand Early Detection 4/1/2026

    Superpower, the first all-in-one proactive health platform, announced a strategic partnership with GRAIL, Inc. (Nasdaq: GRAL) to bring members access to the Galleri® multi-cancer early detection (MCED) test.

  4. Breaking The PCR-Only Barrier: Dual 510(k) Clearance And CLIA-Waiver Establish FINDER As The First Molecular Point-Of-Care Platform With Multifunctional Capabilities 3/31/2026

    Baebies announced FDA 510(k) clearance and CLIA-waiver approval for the FINDER® Flu A&B/SARS-CoV-2 Test, an ultra-rapid RT-PCR assay on the FINDER platform.

  5. Thermo Fisher Scientific Launches Thermo Scientific Glacios 3 Cryo-TEM 3/31/2026

    Thermo Fisher Scientific, the world leader in serving science, today introduces a next-generation cryogenic transmission electron microscope (cryo-TEM) designed to help scientists understand structural biology with greater clarity — now accessible in more lab environments than ever before.

  6. LabConnect Launches SampleGISTICS® 2.0 To Digitize Clinical Trial Sample Capture 3/31/2026

    LabConnect, a global provider of central laboratory services and functional service provider solutions for clinical trials, today announced the launch of SampleGISTICS® 2.0, an application that enables clinical research sites to scan, record and transmit participant sample information.

  7. Takara Bio USA And Hamilton Company Partner To Automate NGS Library Preparation 3/30/2026

    Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., and Hamilton Company announced a development and co-marketing agreement to deliver integrated, automated next-generation sequencing (NGS) library preparation workflows to laboratories worldwide.

  8. Ataraxis AI Launches Ataraxis Breast CTX, The First Predictive AI Test Estimating Individualized Chemotherapy Benefit In Breast Cancer 3/30/2026

    Ataraxis AI, a frontier artificial intelligence (AI) research lab developing AI-powered tools for oncology, today announced Ataraxis Breast CTX, a new predictive capability within its Ataraxis Breast platform, designed to help estimate individualized chemotherapy benefit in breast cancer patients.

  9. Lunit, CellCarta Announce Strategic Collaboration To Accelerate AI-Enabled Digital Pathology For Companion Diagnostic Programs 3/30/2026

    Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision oncology, and CellCarta, a leading global contract research organization (CRO) laboratory to the biopharmaceutical industry, today announced a strategic partnership to accelerate adoption of AI-enabled digital pathology workflows across translational research, clinical trials and companion diagnostic (CDx) programs.

  10. Roche Receives FDA 510(k) Clearance For Cobas® C703 And Cobas® ISE Neo, Next-Generation Analytical Units Enhancing Efficiency And Capability For Laboratories 3/30/2026

    Roche announced today the U.S. Food and Drug Administration (FDA) 510(k) clearance of its newest analytical units – the cobas® c 703 and cobas® ISE neo.